The prostate gland exists in men at the base of the bladder. There is a one in six chance of a man developing prostate cancer, but it can often be cured. Once prostate cancer spreads is it usually incurable. Treatment can range from surgery to chemotherapy to 'active surveillance'. Clinical trials are important to move many of these treatments forward.
Prostate cancer is the most common cancer in Australia. It can often be cured but if it spreads it can be very deadly.
The ENZAMET trial is for men with metastatic prostate cancer commencing androgen deprivation therapy.
The ENZARAD trial is for men with localised prostate cancer at high risk for
recurrence deemed suitable for external beam radiation therapy.
This trial is for men with localised prostate cancer at high risk for recurrence deemed suitable for external beam radiation therapy.
This trial is aimed at men with prostate cancer that has spread to other parts of the body and has continued to grow despite standard treatment (including hormonal treatment and docetaxel chemotherapy), and where the next best step is cabazitaxel chemotherapy.